Literature DB >> 11528421

Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter.

I A Sharpe1, J Gehrmann, M L Loughnan, L Thomas, D A Adams, A Atkins, E Palant, D J Craik, D J Adams, P F Alewood, R J Lewis.   

Abstract

Cone snails use venom containing a cocktail of peptides ('conopeptides') to capture their prey. Many of these peptides also target mammalian receptors, often with exquisite selectivity. Here we report the discovery of two new classes of conopeptides. One class targets alpha1-adrenoceptors (rho-TIA from the fish-hunting Conus tulipa), and the second class targets the neuronal noradrenaline transporter (chi-MrIA and chi-MrIB from the mollusk-hunting C. marmoreus). rho-TIA and chi-MrIA selectively modulate these important membrane-bound proteins. Both peptides act as reversible non-competitive inhibitors and provide alternative avenues for the identification of inhibitor drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528421     DOI: 10.1038/nn0901-902

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  42 in total

Review 1.  Venom effects on monoaminergic systems.

Authors:  Aviva Weisel-Eichler; Frederic Libersat
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2004-05-25       Impact factor: 1.836

Review 2.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxins.

Authors:  Tse Siang Kang; Zoran Radić; Todd T Talley; Seetharama D S Jois; Palmer Taylor; R Manjunatha Kini
Journal:  Biochemistry       Date:  2007-02-22       Impact factor: 3.162

4.  Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties.

Authors:  Pieter Okkerse; Justin L Hay; Elske Sitsen; Albert Dahan; Erica Klaassen; William Houghton; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2016-12-16       Impact factor: 4.335

5.  Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways.

Authors:  Helena Safavi-Hemami; Shane E Brogan; Baldomero M Olivera
Journal:  J Proteomics       Date:  2018-05-16       Impact factor: 4.044

6.  Diversity of conotoxin types from Conus californicus reflects a diversity of prey types and a novel evolutionary history.

Authors:  C A Elliger; T A Richmond; Z N Lebaric; N T Pierce; J V Sweedler; W F Gilly
Journal:  Toxicon       Date:  2010-12-21       Impact factor: 3.033

7.  Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.

Authors:  L Quinton; E Girard; A Maiga; M Rekik; P Lluel; G Masuyer; M Larregola; C Marquer; J Ciolek; T Magnin; R Wagner; J Molgó; R Thai; C Fruchart-Gaillard; G Mourier; J Chamot-Rooke; A Ménez; S Palea; D Servent; N Gilles
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 8.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Deep venomics reveals the mechanism for expanded peptide diversity in cone snail venom.

Authors:  Sébastien Dutertre; Ai-hua Jin; Quentin Kaas; Alun Jones; Paul F Alewood; Richard J Lewis
Journal:  Mol Cell Proteomics       Date:  2012-11-14       Impact factor: 5.911

10.  Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats.

Authors:  S Palea; A Maiga; V Guilloteau; M Rekik; M Guérard; C Rouget; P Rischmann; H Botto; P Camparo; P Lluel; N Gilles
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.